Genetic Tools and Technologies Related News

Oxitec to Apply New Generation of Self-Limiting Mosquito Technology to Malaria-Spreading Mosquitoes

Oxitec’s first step into global malaria vector control efforts in partnership with the Bill & Melinda Gates Foundation Agreement covers the first strain of Oxitec’s genetically-engineered mosquitoes specifically designed to combat malaria vector Oxford, June 19, 2018– Oxitec, Ltd. [...]

CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Announce Grant of U.S. Patent for CRISPR/Cas9 Genome Editing

Patent granted for groundbreaking work by Jennifer Doudna's and Emmanuelle Charpentier's research teams in CRISPR/Cas9 genome editing technology Patent covers use of optimized guide RNA molecules ZUG, Switzerland and CAMBRIDGE, Mass. and BERKELEY, Calif., June 19, 2018 (GLOBE NEWSWIRE) [...]

Japanese Patent Office Grants Broad Claims Covering CRISPR/Cas9 Gene Editing Technology

Dublin/Ireland, June 15, 2018 – ERS Genomics announced today that the Japanese Patent Office has granted Dr. Emmanuelle Charpentier, ERS Genomics’ co-founder, together with the University of California and University of Vienna, its first Japanese patent with broad claims covering [...]

New England Biolabs® Scientists Push the Limits of Golden Gate Assembly

New publication maps ligase fidelity profiles with single molecule real-time sequencing to enable 20+ fragment assemblies with high efficiency and accuracy IPSWICH, Mass., June 11, 2018 /PRNewswire/ -- Some of today's most exciting molecular biology engineering — including the creation [...]

Synthego Launches Engineered Cells Product Portfolio as Next Step in Delivering Genome Engineering Access to All Scientists

Engineered Cells single-click ordering and knockout guarantee removes barriers to world-class CRISPR results REDWOOD CITY, Calif., June 6, 2018 /PRNewswire/ -- Synthego, the leading genome engineering solutions company, launches its Engineered Cells Portfolio with immediate access to Knockout Clone and Pool, [...]

Programmed for safety: How Synvivia is commercializing biocontainment technology

Gabriel Lopez is the founder and CEO of Synvivia, a startup in the San Francisco Bay Area that makes ON-OFF switches for engineered organisms. During his Ph.D. at UC Berkeley, Gabriel developed a genetically encoded biosafety strategy based on ligand-dependent [...]